Michael G. Goggins, MBBCH, MD, is professor of pathology, medicine and oncology at the Johns Hopkins University School of Medicine. He serves as director of the Pancreatic Cancer Early Detection Laboratory and is an attending physician in medicine in the Division of Gastroenterology and Hepatology at The Johns Hopkins Hospital, as well as a molecular biologist.
Dr. Goggins’ research interests include the role of germline BRCA2 mutations in pancreas cancer and characterizing the molecular genetic progression model for pancreas cancer.
He obtained his medical degree in 1988 from Trinity College of the University of Dublin. He completed a residency in internal medicine and a fellowship in gastroenterology at St. James’ Hospital in Dublin. He obtained his membership of the Royal College of Physicians of Ireland in 1991 and his European Diploma in gastroenterology in 1995. He joined the Johns Hopkins faculty in 1999.
Dr. Goggins is a member of the Royal College of Physicians and the European Board of Gastroenterology. He sits on the editorial boards of the scientific journals Gut, Clinical Gastroenterology and Hepatology, and Cancer Biology and Therapy.